NervGen Pharma Corp. (TSXV:NGEN)
Canada · Delayed Price · Currency is CAD 5.85
-0.10 (-1.68%)
Dec 1, 2025, 2:50 PM EST
NervGen Pharma Employees
NervGen Pharma had 7 employees as of December 31, 2019.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
466.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2019 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 745 |
NervGen Pharma News
- 7 days ago - NervGen Pharma GAAP EPS of -$0.06 - Seeking Alpha
- 7 days ago - NervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates - Newsfile Corp
- 7 days ago - NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury - Newsfile Corp
- 11 days ago - NervGen Pharma Announces Closing of US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development - Newsfile Corp
- 12 days ago - NervGen Pharma announces $10M non-brokered private placement - Seeking Alpha
- 12 days ago - NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development - Newsfile Corp
- 3 months ago - NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders - Newsfile Corp
- 3 months ago - NervGen Pharma's NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury - Newsfile Corp